Group Introduction: Difference between revisions

From yangwa
No edit summary
No edit summary
Line 138: Line 138:
       <img src="https://via.placeholder.com/100" />
       <img src="https://via.placeholder.com/100" />
       <h4>Li Jie</h4>
       <h4>Li Jie</h4>
      <p>Intern</p>
    </div>
    <div class="card">
      <img src="https://via.placeholder.com/100" />
      <h4>Boxuan Shen</h4>
       <p>Intern</p>
       <p>Intern</p>
     </div>
     </div>

Revision as of 16:24, 14 April 2025

Synthetic BioPharmaceutics Group

(合成生物药剂学课题组)

🔬 Research Focus

DNA/RNA Origami for Therapy Design of 2D and 3D DNA/RNA nanostructures to deliver siRNA, aptamers, and proteins with precise spatial control and responsiveness to tumor cues.
Logic-Gated Immune Activation We engineer aptamer–antibody logic systems and RNA circuits that enable conditional T cell activation within immunosuppressive tumor environments.
Peptide–DNA Conjugates for Receptor Clustering We create pH-responsive peptide–DNA materials that self-assemble in acidic tumor microenvironments to cluster death receptors (e.g., TRAIL-R) and induce apoptosis.

👤 Current Members

Yang Wang 王蛘

Xie Guangneng 谢广能

Student 研究生

Xu Anran 徐安然

PhD Student 研究生

Zhang Wei

Master Student

Li Jie

Intern

Boxuan Shen

Intern

📚 Selective Publications 代表性论文

  • Wang Y, et al. Programmable DNA robot for cancer therapy. Nature Nanotechnology, 2024.

📞 Contact

📍 West China School of Pharmacy, Sichuan University

📧 13547820971@163.com

🌐 yangwalab.com